These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 23027168

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insights from the use in clinical practice of eculizumab in adult patients with atypical hemolytic uremic syndrome affecting the native kidneys: an analysis of 19 cases.
    Fakhouri F, Delmas Y, Provot F, Barbet C, Karras A, Makdassi R, Courivaud C, Rifard K, Servais A, Allard C, Besson V, Cousin M, Châtelet V, Goujon JM, Coindre JP, Laurent G, Loirat C, Frémeaux-Bacchi V.
    Am J Kidney Dis; 2014 Jan; 63(1):40-8. PubMed ID: 24021908
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Eculizumab for the treatment of atypical hemolytic uremic syndrome: case report and revision of the literature].
    Vaisbich MH, Henriques Ldos S, Watanabe A, Pereira LM, Metran CC, Malheiros DA, Modanez F, Silva JD, Vieira S, Macedo AC, Massarope B, Furusawa EA, Schvartsman BG.
    J Bras Nefrol; 2013 Jan; 35(3):237-41. PubMed ID: 24100744
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab.
    Köse O, Zimmerhackl LB, Jungraithmayr T, Mache C, Nürnberger J.
    Semin Thromb Hemost; 2010 Sep; 36(6):669-72. PubMed ID: 20865644
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical grand rounds: atypical hemolytic uremic syndrome.
    Hodgkins KS, Bobrowski AE, Lane JC, Langman CB.
    Am J Nephrol; 2012 Sep; 35(5):394-400. PubMed ID: 22517061
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O, Balzamo E, Charbit M, Biebuyck-Gougé N, Salomon R, Dragon-Durey MA, Frémeaux-Bacchi V, Niaudet P.
    Am J Kidney Dis; 2010 May; 55(5):923-7. PubMed ID: 20202729
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Eculizumab in the treatment of atypical hemolytic uremic syndrome in infants.
    Ariceta G, Arrizabalaga B, Aguirre M, Morteruel E, Lopez-Trascasa M.
    Am J Kidney Dis; 2012 May; 59(5):707-10. PubMed ID: 22196848
    [Abstract] [Full Text] [Related]

  • 15. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [Abstract] [Full Text] [Related]

  • 16. Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.
    Sinibaldi S, Guzzo I, Piras R, Bresin E, Emma F, Dello Strologo L.
    Pediatr Transplant; 2013 Dec; 17(8):E177-81. PubMed ID: 24118826
    [Abstract] [Full Text] [Related]

  • 17. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
    Tran H, Chaudhuri A, Concepcion W, Grimm PC.
    Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
    [Abstract] [Full Text] [Related]

  • 18. [A case of atypical hemolytic uremic syndrome successfully weaned from plasma exchange by treatment with eculizumab].
    Nagata A, Ohara A, Wakasugi D, Natori C, Ito S, Taguchi K, Fukami K, Okuda S.
    Nihon Jinzo Gakkai Shi; 2014 Mar; 56(5):606-11. PubMed ID: 25130033
    [Abstract] [Full Text] [Related]

  • 19. Maintenance of kidney function following treatment with eculizumab and discontinuation of plasma exchange after a third kidney transplant for atypical hemolytic uremic syndrome associated with a CFH mutation.
    Davin JC, Gracchi V, Bouts A, Groothoff J, Strain L, Goodship T.
    Am J Kidney Dis; 2010 Apr; 55(4):708-11. PubMed ID: 19854549
    [Abstract] [Full Text] [Related]

  • 20. Posttransplant recurrence of atypical hemolytic uremic syndrome.
    Valoti E, Alberti M, Noris M.
    J Nephrol; 2012 Apr; 25(6):911-7. PubMed ID: 22760880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.